- Pulmonary metastases in hepatoblastoma
. - Timing of 11p15.5 alterations during development defines different modes of evolution toward hepatoblastoma with various clinical presentations
. - Proteomic study of childhood liver cancer
.
- Single Center Experience of Congenital Heart Defects in Patients with Hepatoblastoma
. - The Therapeutic Potential of Dinaciclib in Hepatoblastoma
. - Is Resection an Alternative to Transplantation in Locally Advanced Hepatoblastoma? A Systematic review and analysis of pooled individual patient data
. - Patient-derived organoids as new in vitro model for the study of hepatoblastoma
. - Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS)
. - Liver transplantation in pediatric patients with biliary complications after partial liver resection
. - Primary Liver Tumors and Metastases Resection in Children: The Potential of Fluorescence-Guided Techniques
. - Whole genome and transcriptome analysis of 200 pediatric liver cancer in the JPLT study
Abstract preparation
Eligibility
All material submitted must be original and the data should not have been published or presented.
Ethics
Evidence of ethical approval must be included in abstracts involving animal or human studies. There may be exceptions; the rules of the Institutional Ethics Review Board should be followed for retrospective studies.
Regular abstracts should be structured in four parts:
- Aim of the Study
- Methods
- Main results
- Conclusions
Case reports should be structured in three parts:
- Aim of the study
- Case description
- Conclusions
Each abstract should be limited to a maximum of 250 words. Only one table or figure can be included. Abstract can be prepared in Word (or any other text editor).